Nucleocapsid formation and RNA synthesis of Marburg virus is dependent on two coiled coil motifs in the nucleoprotein

Virology Journal

Volumn 4, Issue , 2007, Pages

  DiCarlo, Andrea ^a,b   Möller, Peggy ^a,c   Lander, Angelika ^a,d   Kolesnikova, Larissa ^a,d   Becker, Stephan ^a,d  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b Promega GmbH   (Germany)

^c PAUL EHRLICH INSTITUT   (Germany)

^d ROBERT KOCH INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOPROTEIN; UNCLASSIFIED DRUG; VIRUS FUSION PROTEIN; VIRUS PROTEIN; VIRUS PROTEIN 30; VIRUS PROTEIN 35; NUCLEOCAPSID PROTEIN; VIRUS RNA;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL INCLUSION; FEMALE; HUMAN; HUMAN CELL; MARBURG VIRUS; NUCLEOTIDE SEQUENCE; PROTEIN INTERACTION; PROTEIN MOTIF; RNA SYNTHESIS; VIRUS NUCLEOCAPSID; VIRUS REPLICATION; VIRUS TRANSCRIPTION; BIOSYNTHESIS; CHEMISTRY; GENETIC TRANSCRIPTION; GENETICS; HELA CELL; PHYSIOLOGY;

LAKE VICTORIA MARBURGVIRUS;

CONSERVED SEQUENCE; HELA CELLS; HUMANS; MARBURGVIRUS; NUCLEOCAPSID PROTEINS; NUCLEOPROTEINS; RNA, VIRAL; TRANSCRIPTION, GENETIC; VIRAL PROTEINS;

EID: 37749002547     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-4-105     Document Type: Article

References (23)

1. Über eine bisher unbekannte, von Affen übertragene Viruserkrankung: Marburg-VirusKrankheit. GA Martini HG Kanuff HA Schmidt G Mayer G Baltzer, Dtsch Med Wochenschr 1968 93 559 571 4966280
2. Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment. KM Daddario-DiCaprio TW Geisbert U Stroher JB Geisbert A Grolla EA Fritz L Fernando E Kagan PB Jahrling LE Hensley SM Jones H Feldmann, Lancet 2006 367 1399 1404 10.1016/S0140-6736(06)68546-2 16650649
3. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. SM Jones H Feldmann U Stroher JB Geisbert L Fernando A Grolla HD Klenk NJ Sullivan VE Volchkov EA Fritz KM Daddario LE Hensley PB Jahrling TW Geisbert, Nat Med 2005 11 786 790 10.1038/nm1258 15937495
4. Outbreak of Marburg Virus Hemorrhagic Fever - Angola, Ocotber 1, 2004-March 29, 2005. CDC, MMWR, Morbidity and Mortality Weekly Report 2005 54
5. Marburg haemorrhagic fever in Uganda. WHO, Epidemic and Pandemic Alert and Response (EPR) 2007
6. Interactions of Marburg virus nucleocapsid proteins. S Becker C Rinne U Hofsäss H-D Klenk E Mühlberger, Virology 1998 249 406 417 10.1006/viro.1998.9328 9791031
7. The nucleoprotein of Marburg virus is phosphorylated. S Becker S Huppertz HD Klenk H Feldmann, J Gen Virol 1994 75 Pt 4 809 818 8151297
8. Ultrastructural organization of recombinant Marburg virus nucleoprotein: comparison with Marburg virus inclusions. L Kolesnikova E Mühlberger E Ryabchikova S Becker, J Virol 2000 74 3899 3904 10729166 10.1128/JVI.74.8.3899- 3904.2000
9. Morphology of Marburg virus NP-RNA. M Mavrakis L Kolesnikova GBS Schoehn RWH Ruigrok, Virology 2002 296 300 307 10.1006/viro.2002.1433 12069528
10. Homo-oligomerization of Marburgvirus VP35 is essential for its function in replication and transcription. P Möller N Pariente HD Klenk S Becker, J Virol 2005 79 14876 14886 16282487 10.1128/JVI.79.23.14876-14886.2005
11. Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems. E Mühlberger M Weik VE Volchkov H-D Klenk S Becker, J Virol 1999 73 2333 2342 9971816
12. Three of the four nucleocapsid proteins of Marburg virus, NP, VP35, and L, are sufficient to mediate replication and transcription of Marburg virus-specific monocistronic minigenomes. E Mühlberger B Lotfering H-D Klenk S Becker, J Virol 1998 72 8756 8764 9765419
13. Mutations within the 5' nontranslated RNA of cell culture-adapted hepatitis A virus which enhance cap-independent translation in cultured African green monkey kidney cells. DE Schultz M Honda LE Whetter KL McKnight SM Lemon, J Virol 1996 70 1041 1049 8551562
14. Oligomerization of Ebola virus VP30 is essential for viral transcription and can be inhibited by a synthetic peptide. B Hartlieb J Modrof E Mühlberger HD Klenk S Becker, J Biol Chem 2003 278 41830 41836 10.1074/jbc.M307036200 12912982
15. Predicting coiled coils from protein sequences. A Lupas M Van Dyke J Stock, Science 1991 252 1162 1164 10.1126/science.252.5009.1162
16. Coiled coils: a highly versatile protein folding motif. P Burkhard J Stetefeld SV Strelkov, Trends Cell Biol 2001 11 82 88 10.1016/S0962-8924(00) 01898-5 11166216
17. Alpha-helical coiled coils: more facts and better predictions. C Cohen DA Parry, Science 1994 263 488 489 10.1126/science.8290957 8290957
18. Hantavirus Nucleocapsid Protein Coiled-Coil Domains. A Alfadhli E Steel L Finlay HP Bachinger E Barklis, J Biol Chem 2002 277 27103 27108 10.1074/jbc.M203395200 12019266
19. Structure of the vesicular stomatitis virus nucleoprotein-RNA complex. TJ Green X Zhang GW Wertz M Luo, Science 2006 313 357 360 10.1126/science.1126953 16778022
20. Functional mapping of the nucleoprotein of Ebola virus. S Watanabe T Noda Y Kawaoka, J Virol 2006 80 3743 3751 16571791 10.1128/JVI.80.8.3743-3751.2006
21. A highly conserved region of the Sendai virus nucleocapsid protein contributes to the NP-NP binding domain. TM Myers A Pieters SA Moyer, Virology 1997 229 322 335 10.1006/viro.1996.8429 9126246
22. Domains of the measles virus N protein required for binding to P protein and self-assembly. B Bankamp SM Horikami PD Thompson M Huber M Billeter SA Moyer, Virology 1996 216 272 277 10.1006/viro.1996.0060 8615002
23. Protein interaction domains of the measles virus nucleocapsid protein (NP). P Liston R Batal C DiFlumeri DJ Briedis, Arch Virol 1997 142 305 321 10.1007/s007050050078 9125045